Urologix

ULGX

Company. Urologix "develop[s], manufacture[s] and market[s] medical devices for the treatment of urological disorders. Our cutting edge technologies have revolutionized urological therapy and created effective new treatment options for a wide range of patients with benign prostatic hyperplasia (BPH)." (company website)

ULGX stock chart

Buy. This is my third attempt to make money off this company. The first lot netted a profit of 7%. The second lot netted a loss of 9%.

I bought this third lot of ULGX last week when it broke the $14 level, having concluded that the sale on 17-May was premature. This week it reached another new high of $15.28, but on a down-day, and it has been downhill from there.

profit Bottom line
+2.5%

Sell. When I saw ULGX struggling again today, a day when the stock market was buoyed by good economic news, I decided to pull the plug.

Ironically, my three purchases, taken together, amount to a wash. And that's a pissy outcome.